Patent Assignment
Reel/Frame 027661/0444
Merger
Recorded: 2012-02-07
Pages: 4
Assignor
TROVIS PHARMACEUTICALS LLC
Executed: 2011-06-06
Assignee
TROVIS PHARMACEUTICAL HOLDINGS, INC.
909 THIRD AVENUE, NEW YORK, NEW YORK, 10022-4731
Covered Property
(1)
Therapeutic Agent for Glaucoma Containing Adenosine Derivative as Active Ingredient
Application:
12/450,832 →
Publication:
US 2010/0093770
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 14, 2009
From: SHIMAZAKI, ATSUSHI; KAWABATA, NORIKO; KIRIHARA, TOMOKO; RIEGER, JAYSON M.
To: SANTEN PHARMACEUTICAL CO., LTD.; PGXHEALTH, LLC
Reel/Frame 023398/0068 →
Change of Name
Jan 28, 2011
From: PGXHEALTH, LLC
To: TROVIS PHARMACEUTICALS, LLC
Reel/Frame 025709/0994 →
Merger
Feb 8, 2012
From: TROVIS PHARMACEUTICALS HOLDINGS, INC.
To: CLINICAL DATA, INC.
Reel/Frame 027669/0650 →
Assignment of Assignor's Interest
Feb 9, 2012
From: CLINICAL DATA, INC.
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 027677/0712 →
Assignment of Assignor's Interest
Feb 13, 2012
From: DOGWOOD PHARMACEUTICALS, INC.
To: FOREST LABORATORIES HOLDINGS LIMITED
Reel/Frame 027690/0771 →